Impact of the variant allele frequency ofASXL1,DNMT3A,JAK2,TET2,TP53, andNPM1on the outcomes of patients with newly diagnosed acute myeloid leukemia-Reference-Cited by-同舟云学术

Impact of the variant allele frequency ofASXL1,DNMT3A,JAK2,TET2,TP53, andNPM1on the outcomes of patients with newly diagnosed acute myeloid leukemia

Published:2019-11-19 Issue:4 Volume:126 Page:765-774
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sasaki Koji¹²^ORCID,Kanagal‐Shamanna Rashmi³^ORCID,Montalban‐Bravo Guillermo¹,Assi Rita¹⁴,Jabbour Elias¹^ORCID,Ravandi Farhad¹,Kadia Tapan¹^ORCID,Pierce Sherry¹,Takahashi Koichi¹,Nogueras Gonzalez Graciela⁵,Patel Keyur³,Soltysiak Kelly A.¹,Cortes Jorge¹,Kantarjian Hagop M.¹^ORCID,Garcia‐Manero Guillermo¹^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

2. Department of Hematology Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University Tokyo Japan

3. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas

4. Division of Hematology‐Oncology Lebanese American University and Lebanese American University Medical Center‐Rizk Hospital Beirut Lebanon

5. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas

Funder

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32566

Reference22 articles.

3. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

4. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

5. Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WT1 And DNMT3A Mutations in Prognostic Significance of Acute Myeloid Leukemia: A Meta-Analysis;Cancer Biotherapy and Radiopharmaceuticals;2024-08-29

2. High Expression of ARHGEF5 Predicts Unfavorable Prognosis in Acute Myeloid Leukemia;2024-06-13

3. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22

4. Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.;2024-03-25

5. Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches;Frontiers in Oncology;2024-02-12